Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zytiga
Zytiga
McKinsey's 4 drug launch flavors: Good, bad, ugly and misguided
Fierce Pharma
Wed, 05/18/16 - 04:27 pm
drug launches
JNJ
Zytiga
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Fierce Pharma Marketing
Wed, 05/20/15 - 06:15 pm
Medivation
Xtandi
Astellas
JNJ
Zytiga
Are Sales for This J&J Drug About to Stall?
Investopedia
Mon, 04/13/15 - 09:59 pm
JNJ
Zytiga
prostate cancer
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Sovaldi
Gilead Sciences
Eyelea
Tecfidera
Zytiga
Kalydeco
Vertex Pharmaceuticals
Victoza
Novo Nordisk
Gilenya
Yervoy
Xtandi
Stribild
Stelara
3 Drugs Critical to Johnson & Johnson's Future
Motley Fool
Tue, 10/21/14 - 09:20 am
JNJ
Olysio
Zytiga
Invega Sustenna
Xarelto
Stelara
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Zytiga
Xtandi
JNJ
prostate cancer
Medivation
Astellas
Xtandi field force to increase by 50% for market-share battle with Zytiga
Fierce Pharma Marketing
Mon, 09/15/14 - 07:30 pm
Xtandi
Medivation
Astellas
hirings
JNJ
Zytiga
Is This Johnson & Johnson's Worst Nightmare?
Motley Fool
Tue, 07/8/14 - 04:07 pm
JNJ
Zytiga
Medivation
Xtandi
Olysio
Gilead Sciences
Sovaldi
UK body blocks earlier use of J&J prostate cancer drug
Yahoo/Reuters
Tue, 05/13/14 - 10:14 pm
UK
prostate cancer
JNJ
Zytiga
Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave
Fierce Pharma Marketing
Thu, 05/8/14 - 12:30 pm
oncology
JNJ
Roche
Celgene
Zytiga
Kadcyla
Nexavar
Gleevec
Drugs That Will Help Johnson & Johnson Grow By 5% In 2014
Forbes
Wed, 04/30/14 - 10:28 am
JNJ
Remicade
Olysio
Velcade
Zytiga
5 Biotechs With Prostate Cancer Treatments Worth Watching
Motley Fool
Sun, 04/6/14 - 10:21 am
JNJ
Zytiga
Xofigo
Bayer
Dendreon
Provenge
prostate cancer
Seattle Genetics
Progenics
Don't bet on a home-run drug launch, even for power-hitting drugs
Fierce Pharma
Wed, 03/19/14 - 03:50 pm
drug launches
JNJ
Zytiga
Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Motley Fool
Wed, 01/29/14 - 05:46 pm
Medivation
Astellas
JNJ
Zytiga
Xtandi
prostate cancer
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Motley Fool
Thu, 01/23/14 - 08:22 am
JNJ
Zytiga
Medivation
Xtandi
prostate cancer
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
JNJ
Medivation
prostatce cancer
Astellas
Dendreon
Sanofi
Zytiga
Xtandi
Provenge
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
JNJ
Medivation
prostate cancer
Xtandi
Astellas
Zytiga
Dendreon, Zogenix, and Ampio Pharmaceuticals Could Be Big Movers Today
Motley Fool
Mon, 10/28/13 - 09:33 am
Dendreon
Zogenix
Ampio Pharmaceuticals
prostate cancer
Medivation
Zytiga
Provenge
Zohydro ER
Ampion
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
How Johnson & Johnson Plans to Win the Prostate Cancer Battle
Motley Fool
Sat, 09/28/13 - 12:17 pm
Zytiga
prostate cancer
JNJ
Pages
« first
‹ previous
1
2
3
4
next ›
last »